1. A FIM Study to Assess Safety and Exposure of Inhaled Single Doses of AP301—A Specific ENaC Channel Activator for the Treatment of Acute Lung Injury. (March 2014) Authors: Schwameis, Richard; Eder, Sandra; Pietschmann, Helmut; Fischer, Bernhard; Mascher, Hermann; Tzotzos, Susan; Fischer, Hendrik; Lucas, Rudolf; Zeitlinger, Markus; Hermann, Robert Journal: Journal of clinical pharmacology Issue: Volume 54:Number 3(2014:Mar.) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Stapled peptides as potential inhibitors of SARS‐CoV‐2 binding to the hACE2 receptor. (26th February 2022) Authors: Tzotzos, Susan Journal: Journal of peptide science Issue: Volume 28:Number 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗